• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Ardelyx, Inc. - Common Stock (NQ:ARDX)

    6.375 -0.075 (-1.16%)
    Streaming Delayed Price Updated: 11:58 AM EDT, Apr 20, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,242,881
    Open 6.400
    Bid (Size) 6.370 (1,100)
    Ask (Size) 6.380 (1,200)
    Prev. Close 6.450
    Today's Range 6.345 - 6.525
    52wk Range 3.210 - 8.400
    Shares Outstanding 103,119,010
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026
    Conference call scheduled for 4:30 p.m. Eastern Time 
    From Ardelyx, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +3.7%
    +3.7%
    1 Month
    +20.1%
    +20.1%
    3 Month
    -17.8%
    -17.8%
    6 Month
    +25.0%
    +25.0%
    1 Year
    +39.8%
    +39.8%

    More News

    Read More
    News headline image
    Ardelyx President and CEO Sells 41,000 Shares for $243,000 ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx
    From Ardelyx, Inc.
    Via GlobeNewswire
    Ardelyx Inc (NASDAQ:ARDX) Reports Q4 2025 Revenue Beat but EPS Miss, Shares Fall ↗
    Via Chartmill
    Ardelyx Stock Rises Premarket As Piper Sees Over 100% Upside — Says Constipation Drug ‘Stole The Show’ With 2026 Guidance ↗
    Via Stocktwits
    News headline image
    Ardelyx Announces Recipients of the 2026 Derek Forfang Patient Advocate Award
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Ardelyx Announces Publication of a Review Article Demonstrating Rapid and Meaningful Symptom Relief with Tenapanor in IBS-C
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Ardelyx to Participate in Upcoming Investor Conferences
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Ardelyx CEO Sells 41k Shares as Company Announces Huge Partnership ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Ardelyx and the LPGA Announce Multi-Year Partnership to Break Stigma Around Digestive Health Issues Impacting Millions
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    ARDX Stock Jumps Over 5% Overnight As Director Loads Up In Vote Of Confidence For Flagship Constipation Drug ↗
    Via Stocktwits
    News headline image
    Nasdaq, S&P 500 Futures Fall On Tariff, Iran Tensions: Why NVDA, NFLX, HON, IBRX, MLTX Are On Traders' Radar Today ↗
    Via Stocktwits
    Topics Artificial Intelligence ETFs Government
    News headline image
    ARDX Stock Is Down Pre-Market After Q4 Earnings Miss, So Why Did This Firm Just Hike Price Target By 80%? ↗
    Via Stocktwits
    Topics Earnings Intellectual Property
    News headline image
    ARDX Stock Slips After Hours As Q4 Earnings Disappoint: Retail Sees Ibsrela Driving Outperformance In Time ↗
    Via Stocktwits
    Topics Artificial Intelligence
    News headline image
    Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Ardelyx Receives New Patent for Tenapanor
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    First Patient Dosed in ACCEL: Phase 3 Chronic Idiopathic Constipation Study of IBSRELA
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Breaking Barriers: How 2026’s Top Clinical Leaders Are Disrupting Chronic Disease Markets
    From Equity Insider
    Via GlobeNewswire
    News headline image
    Ardelyx Stock Is Rallying – What Is Making Retail So Bullish? ↗
    Via Stocktwits
    News headline image
    Ardelyx Reports Preliminary 2025 Revenue and Provides 2026 Strategic Outlook
    From Ardelyx, Inc.
    Via GlobeNewswire
    News headline image
    Ardelyx (ARDX) Q3 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Is Teladoc Stock a Buy After Oracle Investment Management Upped Its Stake? ↗
    Via The Motley Fool
    News headline image
    Real-World Evidence Studies of XPHOZAH® (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week
    From Ardelyx, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Ardelyx, Inc. - Common Stock publicly traded?
    Yes, Ardelyx, Inc. - Common Stock is publicly traded.
    What exchange does Ardelyx, Inc. - Common Stock trade on?
    Ardelyx, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Ardelyx, Inc. - Common Stock?
    The ticker symbol for Ardelyx, Inc. - Common Stock is ARDX on the Nasdaq Stock Market
    What is the current price of Ardelyx, Inc. - Common Stock?
    The current price of Ardelyx, Inc. - Common Stock is 6.375
    When was Ardelyx, Inc. - Common Stock last traded?
    The last trade of Ardelyx, Inc. - Common Stock was at 04/20/26 11:58 AM ET
    What is the market capitalization of Ardelyx, Inc. - Common Stock?
    The market capitalization of Ardelyx, Inc. - Common Stock is 657.38M
    How many shares of Ardelyx, Inc. - Common Stock are outstanding?
    Ardelyx, Inc. - Common Stock has 657M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.